You are here

  • Home
  • Archive
  • Volume 79, Issue 6
  • Response to: ‘Regarding microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints’ by Liebling

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Regarding microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints’ by Liebling
Free

Authors

  • Akihiro Nakamura Arthritis Program, University Health Network, Toronto, Ontario, Canada Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada Division of Rheumatology, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jason S. Rockel Arthritis Program, University Health Network, Toronto, Ontario, Canada Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Mohit Kapoor Arthritis Program, University Health Network, Toronto, Ontario, Canada Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada Department of Surgery, University of Toronto, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr. Mohit Kapoor, Arthritis Program, University Health Network, Toronto, Ontario, Canada; mkapoor{at}uhnresearch.ca
View Full Text

Citation

Nakamura A, Rockel JS, Kapoor M
Response to: ‘Regarding microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints’ by Liebling
Annals of the Rheumatic Diseases 2020;79:e70.

Publication history

  • Received April 13, 2019
  • Accepted April 14, 2019
  • First published May 2, 2019.
Online issue publication 
May 20, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.